April 27, 2020 / 12:41 PM / a month ago

BRIEF-Flexion Therapeutics Says Intends To Initiate Human Trials Of FX301 In 2021

April 27 (Reuters) - Flexion Therapeutics Inc:

* FLEXION THERAPEUTICS - ANNOUNCES POSITIVE PRECLINICAL DATA SUPPORTING DEVELOPMENT OF FX301 FOR POST-OPERATIVE PAIN

* FLEXION THERAPEUTICS INC - NEW ANIMAL DATA SHOW FX301 PROVIDED SUSTAINED, POST-OPERATIVE ANALGESIC EFFECT WITH NO IMPAIRMENT IN MOTOR FUNCTION

* FLEXION THERAPEUTICS INC - INTEND TO INITIATE HUMAN TRIALS IN 2021 FOR FX301 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below